Full Breakdown
Unmet Mental Health Care Needs Among Canadian Postpartum Parents
2/10/2026, 12:11:13 PM
Overview of the Survey Findings
A recent survey conducted by Statistics Canada reveals significant mental health challenges faced by Canadian mothers and birthing parents during the postpartum period. The 2024 Parental Experiences Survey, which included responses from 11,153 participants who gave birth between December 31, 2023, and April 29, 2024, found that nearly half of these individuals reported struggling with mental health issues. Notably, 20% indicated they needed mental health care but did not receive it during pregnancy or postpartum.
Key Statistics on Mental Health Challenges
Among those experiencing mental health difficulties, 60% reported that their issues began after childbirth, while 25% noted the onset during pregnancy, and 15% experienced challenges prior to becoming pregnant. Alarmingly, 21% of respondents stated that no healthcare provider inquired about their emotional well-being during these critical periods. Disparities were evident, with 30% of racialized mothers and birthing parents and 33% of recent immigrants reporting they were not asked about their mental health.
Barriers to Accessing Care
The survey highlighted several barriers to accessing mental health care. Fifty-four percent of respondents cited long wait times as the primary obstacle, while 33% found the available care unhelpful. Additionally, 21% expressed uncertainty about how or where to seek help, and 19% felt too busy to prioritize mental health care. Only 2% of those with mental health challenges sought emergency care or hospitalization for their issues.
Expert Insights on Care Disparities
Lucy Barker, a psychiatrist and early-career scientist at Women’s College Hospital, emphasized the importance of healthcare providers proactively asking about mental health. She noted that the survey underscores the need for equitable access to care, stating, “That really speaks to the importance of making sure that care is equitable and making sure that everyone has access to the care that they need.”
Recent Developments in Treatment
In December 2025, Health Canada approved Zuranolone, a medication designed to treat postpartum depression. This drug targets gamma-aminobutyric acid receptors in the brain, which play a role in mood regulation. It is recommended for individuals experiencing moderate to severe postpartum depression, as assessed by the level of impairment in daily functioning.
Conclusion: The Path Forward
The findings of the 2024 Parental Experiences Survey highlight the urgent need for improved mental health support for postpartum parents in Canada. Addressing the barriers to care and ensuring that all individuals are routinely asked about their mental health could significantly enhance access to necessary services. As Barker noted, “During pregnancy and postpartum, there is a lot going on... it can be difficult to get to appointments for their mental health.” The ongoing challenge remains to create a healthcare environment where mental health is prioritized and accessible for all.
